The significance of NLRP3 activation in ovarian cancer is further confirmed by a study by Li et al. [226], where they found that NLRP3 is overexpressed in ovarian cancer and is correlated with the poor survival rate and cisplatin resistance to ovarian cancer. The gene discussed is NLRP3; the disease is ovarian cancer.